[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gonzalez et al., 1996 - Google Patents

Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: preliminary study

Gonzalez et al., 1996

Document ID
17555190905040750010
Author
Gonzalez J
Berger C
Cottrill C
Geller A
Schwartz J
Palangio M
Klainer A
Bisaccia E
Publication year
Publication venue
Photochemistry and photobiology

External Links

Snippet

Extracorporeal photochemotherapy (photopheresis), an immunomodulatory therapy that targets circulating T helper lymphocytes, has been applied to the management of human immunodeficiency virus (HIV) disease. Any therapy that exerts its actions on CD4+ T cells …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
    • A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Similar Documents

Publication Publication Date Title
Walker et al. Cytotoxic T lymphocytes against HIV
Ascher et al. AIDS as immune system activation: a model for pathogenesis.
Arnaout et al. HIV–1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?
US4960408A (en) Treatment methods and vaccines for stimulating an immunological response against retroviruses
Littaua et al. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag
Operskalski et al. Blood donations and viruses
JP2000510101A (en) Photopheresis treatment of leukocytes
DE69734450T2 (en) PHOTOPHERESIS TREATMENT OF HCV INFECTIONS
TURANO et al. Inhibitory effect of papaverine on HIV replication in vitro
North et al. Photodynamic inactivation of free and cell-associated HIV-1 using the photosensitizer, benzoporphyrin derivative
Gonzalez et al. Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: preliminary study
FI105453B (en) A method of producing a vaccine against HIV retroviral infection
Ruprecht et al. Murine and simian retrovirus models: the threshold hypothesis
Haynes et al. Update on the issues of HIV vaccine development
Okedoye et al. Mathematical analysis of affinity hemodialysis on t-cell depletion
CA2120001C (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
Gumel et al. A new mathematical model for assessing therapeutic strategies for HIV infection
Fleury et al. Therapeutic vaccine against HIV, viral variability, cytotoxic T lymphocyte epitopes, and genetics of patients
US20030108543A1 (en) Photophoretic auto immune stimulation
Pechère et al. Impact of PUVA therapy on HIV viremia: a pilot study
Bangham et al. What is required of an HIV vaccine?
Bocci et al. The failure of HIV vaccines: A new autovaccine may overcome some problems
Buimovici-Klein et al. Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23
Morrey et al. Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection
Shimazaki et al. Detection of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in donor eyes using polymerase chain reaction.